Here's my thought. When they're running the study, there's a good chance they'll use cogstate battery as established technique to compare against. IF the study is proven to be successful, it'll probably have impact on loyalties that Cogstate receives from healthcare segment? On the other hand, Eli Lily's published successful phase 2 clinical study result of their alzheimer's disease drug, donanemab. I know it'll be years from phase 3 but any successful alzheimer's drug will benefit cogstate.
- Forums
- ASX - By Stock
- CGS
- Biogen and Apple study early signs of Cognitive Impairment
Biogen and Apple study early signs of Cognitive Impairment, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGS (ASX) to my watchlist
|
|||||
Last
92.5¢ |
Change
-0.015(1.60%) |
Mkt cap ! $157.9M |
Open | High | Low | Value | Volume |
92.5¢ | 95.0¢ | 91.5¢ | $157.5K | 170.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3377 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.5¢ | 246 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3377 | 0.925 |
2 | 4891 | 0.915 |
1 | 3800 | 0.910 |
1 | 75032 | 0.900 |
4 | 60261 | 0.890 |
Price($) | Vol. | No. |
---|---|---|
0.935 | 246 | 1 |
0.940 | 9200 | 3 |
0.945 | 3800 | 1 |
0.950 | 4018 | 2 |
0.975 | 43931 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |